How is Thailand New Gene IVF Center? Real Evaluation and Selection Framework

Opening: Real Consultation Scenario

Consultation Scenario · A 34-year-old woman, whose husband is a carrier of β-thalassemia. The couple wishes to have a child free from severe thalassemia. They learned online about Thailand New Gene IVF Center, which specializes in genetic testing, and came to consult whether this center is suitable for their genetic situation.

How to Evaluate Thailand New Gene IVF Center: Six Core Dimensions

Evaluating an overseas assisted reproduction institution should not rely on a single source of information. It requires cross-referencing from six verifiable dimensions. The following framework applies to any institution, including New Gene IVF Center.

• Practice License: Confirm that the institution holds a license for assisted reproductive technology issued by the Thai Ministry of Public Health. Registration information can be verified on the website of the Medical Council of Thailand (MCD). New Gene IVF Center is a legally registered assisted reproduction institution in Thailand, holding licenses to perform IVF, ICSI, PGT, and other technologies.
• Laboratory Standards: The air quality, temperature and humidity control, and equipment configuration of the assisted reproduction laboratory directly affect embryo quality. It is necessary to know whether the center's laboratory meets Class 1000 or Class 10000 laminar flow standards and whether it is equipped with time-lapse imaging incubators, laser-assisted hatching systems, and other equipment.
• Genetic Testing Platform: For an institution named "New Gene," its PGT technology platform is a core evaluation point. It is necessary to confirm whether it uses an NGS or aCGH platform and whether it has the capability for PGT-A, PGT-M, and PGT-SR. The turnaround time for test reports is typically 7–14 business days.
• Embryology Team: The experience of embryologists directly determines key steps such as ICSI operation, embryo culture, and biopsy. It is recommended to learn about the core team members' years of experience, overseas training background, and academic publications.
• Support Services: Including Chinese translation, medical coordination, transportation and accommodation arrangements, legal consultation, etc. These services affect the treatment experience but should not be the primary basis for medical decisions.
• Cost Transparency: Request a detailed fee schedule from the institution, including basic IVF fees, PGT testing fees (per embryo or per cycle), medication fees, cryopreservation fees, etc. Avoid hidden charges.

Differences Between Types of Assisted Reproduction Institutions in Thailand

Assisted reproduction institutions in Thailand can be broadly categorized into three types. New Gene IVF Center is a specialized fertility center, and its positioning and characteristics differ significantly from other types of institutions.

New Gene IVF Center's differentiated advantage lies in its continuous investment in genetics testing, particularly its technical accumulation in PGT-A and PGT-M. Compared to general hospitals, it may have an edge in the depth and turnaround time of genetic testing; compared to similar specialized centers, the update frequency of its technology platform and the scope of its testing panel are key points for horizontal comparison.

Doctor's Perspective: Clinical Value of Genetic Testing in IVF

Preimplantation Genetic Testing (PGT) primarily addresses three types of issues. Doctors recommend the appropriate type based on the patient's specific situation and inform them of the corresponding success rates and limitations.

• PGT-A (Aneuploidy Screening): Suitable for women of advanced maternal age (≥38 years), those with recurrent implantation failure, or recurrent pregnancy loss. The rate of embryonic aneuploidy increases significantly after age 35. At age 38, about 40% of embryos have chromosomal numerical abnormalities; by age 43, this exceeds 70%. PGT-A can select embryos with a normal number of chromosomes for transfer, reducing the miscarriage rate.
• PGT-M (Monogenic Disease Testing): Suitable for cases where one or both partners carry a pathogenic gene, such as thalassemia, spinal muscular atrophy (SMA), hereditary deafness, etc. PGT-M requires constructing haplotypes for linkage analysis, which involves a longer cycle, typically requiring 2–3 months of preliminary preparation.
• PGT-SR (Structural Rearrangement Testing): Suitable for cases where one partner has a chromosomal balanced translocation, Robertsonian translocation, etc. These patients have a high rate of natural miscarriage, and PGT-SR can help select embryos with normal chromosomal structure.

Five Most Easily Overlooked Details

When evaluating overseas IVF institutions, the following details are often overlooked but have a significant impact on treatment outcomes and experience.

1. Testing Platform Update Cycle: NGS platforms iterate quickly, with continuously improving throughput and accuracy. It is necessary to know the model of the testing platform used by the institution and the time of its last upgrade.
2. Embryo Biopsy Technique: The timing of biopsy (Day 3 cleavage stage biopsy vs. Day 5 trophectoderm biopsy), the number of cells biopsied, and the post-biopsy embryo handling method all affect testing accuracy and embryo developmental potential. Day 5 trophectoderm biopsy is the current mainstream technique.
3. Genetic Counseling Support: Genetic counseling before and after PGT testing is very important. The institution needs to have professional genetic counselors or collaborate with genetics departments to help patients understand test results and residual risks.
4. Embryo Cryopreservation Conditions: Embryos are frozen using vitrification and stored in liquid nitrogen at -196°C. It is necessary to check whether the institution's liquid nitrogen monitoring system is robust and whether there are backup power supplies and liquid nitrogen reserves.
5. Legal Compliance: Thailand has clear legal regulations on the application of PGT, including which conditions allow PGT and whether embryo sex selection is permitted. Ensure the institution strictly complies with local laws.

Five Common Misconceptions and Risks

Based on practitioner observations, patients are most prone to the following misconceptions when choosing overseas IVF institutions.

• Misconception 1: Equating "genetic testing" with "guaranteed health". PGT can only screen for known chromosomal abnormalities and gene mutations. It cannot detect all genetic problems, nor can it guarantee the absolute health of the child after birth. Some institutions over-promote the effects of genetic testing; a rational perspective is necessary.
• Misconception 2: Neglecting preliminary examinations. Some patients think they can start the cycle directly upon arrival overseas, but comprehensive fertility assessment, infectious disease screening, genetic counseling, etc., are actually required. These examinations take time.
• Misconception 3: Underestimating the time commitment. A complete overseas IVF cycle, including initial consultation, examinations, ovarian stimulation, egg retrieval, embryo culture, PGT testing, and frozen embryo transfer, typically takes 2–4 months. PGT testing itself requires 7–14 business days. If PGT-M is needed, an additional 2–3 months for haplotype construction is required.
• Misconception 4: Ignoring exchange rate and policy risks. Medical costs in Thailand are settled in Thai Baht, and exchange rate fluctuations can affect actual expenses. Additionally, Thailand's assisted reproduction policies may change; it is important to stay updated on the latest regulations.
• Misconception 5: Placing all hope in one institution. It is recommended that patients prepare backup plans, including domestic treatment options and other overseas institutions, to avoid disruption due to visa issues, policy changes, or personal factors.

Time Planning for an Overseas IVF Cycle (Using PGT-A as an Example)

The standard timeline is as follows; actual cycles may vary due to individual differences.

The total time required is approximately 3 months. If PGT-M is needed, an additional 2–3 months for haplotype construction should be added. For individuals of advanced age, with diminished ovarian reserve, or a history of miscarriage, it is advisable to complete all preliminary examinations 3–6 months in advance.

Frequently Asked Questions

Doctor's Advice: Three Preparation Steps Before Decision-Making

For patients considering Thailand New Gene IVF Center, it is recommended to complete the following three steps before making a final decision.

1. Step 1, Domestic Pre-Assessment: Complete a comprehensive fertility assessment and genetic counseling domestically to clarify your own needs and conditions. This includes AMH, hormone panel, semen analysis, karyotype, genetic testing, etc. Communicating with the overseas institution after a clear diagnosis is more efficient.
2. Step 2, Horizontal Comparison of Institutions: Contact New Gene IVF Center to obtain a detailed medical plan and fee schedule, and request validation data for their technology platform. Simultaneously, conduct comparative consultations with at least 2–3 other institutions, including domestic fertility centers and other overseas specialized centers.
3. Step 3, Risk Assessment and Backup Plans: Understand the potential risks, including time commitment, cost fluctuations, policy changes, medical uncertainties, etc. Develop backup plans to avoid being caught off guard if a single plan fails.